Takeda Pharmaceutical Company Limited
Tetrahydropyridopyrazine modulators of GPR6
Last updated:
Abstract:
Disclosed is a compound of Formula 1, ##STR00001## and a pharmaceutically acceptable salt thereof. This disclosure also relates to materials and methods for preparing the compound of Formula 1, to pharmaceutical compositions which contain it, and to its use for treating diseases, disorders, and conditions associated with GPR6.
Status:
Grant
Type:
Utility
Filling date:
15 Jun 2018
Issue date:
10 Sep 2019